Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-21-013554

Options or other derivatives

  • Chief Financial Officer bought 17,000 shares at $0.38 ($6,460)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Arrow Alexander K. Chief Financial Officer 2021-06-02 Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 +100 $0.38 $38 33,100 D
Arrow Alexander K. Chief Financial Officer 2021-06-03 Purchase · PTIXW Common Stock 5-year warrants strike price $4.98 +16,900 $0.38 $6,422 50,000 D
Loading xslF345X03/ownership.xml…